FONAR Set to Join Russell 3000 Index MELVILLE, N.Y., June

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
162
FONAR Set to Join Russell 3000 Index

MELVILLE, N.Y., June 23, 2017 (GLOBE NEWSWIRE) -- FONAR Corporation (NASDAQ: FONR ), The Inventor of MR Scanning ™, reported today that it is set to join the broad-market Russell 3000 ® Index at the conclusion of the Russell indexes annual reconstitution, effective after the US market opens on June 26, according to a preliminary list of additions posted June 9 and today, June 23.

The annual Russell indexes reconstitution captures the 4,000 largest US stocks as of the end of May, ranking them by total market capitalization. Membership in the US all-cap Russell 3000 ® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000 ® Index or small-cap Russell 2000 ® Index as well as in appropriate growth and value style indexes. FTSE (Financial Times and Stock Exchange) Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.

Raymond Damadian, founder and Chairman of FONAR said, “I am proud of this remarkable milestone for our Company. It is based on our Company’s share price and is an indication that we have been delivering shareholder value. It is a result of the successful strategy we have put in place in recent years that has allowed the Company to be profitable for 28 consecutive quarters.”

Timothy R. Damadian, President and CEO of FONAR said, “FONAR’s inclusion in the Russell 3000 is important because it gives institutions, mutual funds and the investing community greater visibility of our Company. They’re all looking for successful value stocks, and we’ve shown that FONAR can deliver.”

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $8.4 trillion in assets are benchmarked against Russell’s US indexes. Russell indexes are part of FTSE Russell, a leading global index provider. For more information on the Russell 3000® Index and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website.

About FTSE Russell:

FTSE Russell is a leading global index provider creating and managing a wide range of indexes, data and analytic solutions to meet client needs across asset classes, style and strategies. Covering 98% of the investable market, FTSE Russell indexes offer a true picture of global markets, combined with the specialist knowledge gained from developing local benchmarks around the world.

FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $12.5 trillion is currently benchmarked to FTSE Russell indexes. For over 30 years, leading asset owners, asset managers, ETF providers and investment banks have chosen FTSE Russell indexes to benchmark their investment performance and create investment funds, ETFs, structured products and index-based derivatives. FTSE Russell indexes also provide clients with tools for asset allocation, investment strategy analysis and risk management.

A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on index innovation and customer partnership applying the highest industry standards and embracing the IOSCO Principles. FTSE Russell is wholly owned by London Stock Exchange Group.

For more information, visit www.ftserussell.com

About FONAR:

FONAR, The Inventor of MR Scanning™ , located in Melville, NY, was incorporated in 1978 and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's signature product is the FONAR UPRIGHT® Multi-Position™ MRI (also known as the STAND-UP® MRI), the only whole-body MRI that performs Position™ imaging (pMRI™) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as in the conventional lie-down position. The FONAR UPRIGHT® MRI often detects patient problems that other MRI scanners cannot because they are lie-down and "weightless-only" scanners. The patient-friendly UPRIGHT® MRI has a near-zero claustrophobic rejection rate by patients. Regarding patient comfort, as one FONAR customer stated, "If the patient is claustrophobic in this scanner, they'll be claustrophobic in my parking lot." Approximately 85% of patients are scanned sitting while watching TV.

FONAR has new works-in-progress  technology for visualizing and quantifying the flow of cerebrospinal fluid (CSF)  which circulates throughout the brain and vertebral column at the rate of 32 quarts per day. This imaging and quantifying of the dynamics of this vital life-sustaining physiology of the body’s neurologic system has been made possible first by FONAR’s introduction of the MRI and now by this latest works-in-progress method for quantifying CSF flow in all the normal positions of the body, particularly in its upright flow against gravity. Patients with whiplash or other neck injuries are among those who will benefit from this new understanding.

FONAR’s substantial list of patents includes recent patents for its technology enabling full weight-bearing MRI imaging of all the gravity sensitive regions of the human anatomy, especially the brain, extremities and spine. FONAR’s UPRIGHT® Multi-Position™ MRI is the only scanner licensed under these patents.

UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™ , Full Range of Motion™, Multi-Position™ , Upright Radiology™, The Proof is in the Picture™ , True Flow™, pMRI™ , Spondylography™, Dynamic™ , Spondylometry™, CSP™ , and Landscape™, are trademarks of FONAR Corporation.

This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission.

Contact: Daniel Culver Director of Communications E-mail: investor@fonar.com www.fonar.com The Inventor of MR Scanning™ An ISO 9001 Company Melville, New York 11747 Phone: (631) 694-2929 Fax: (631) 390-1772

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Curaleaf Secures Key Approvals in Aurora Acquisition Bid

Updated Category News Views 100

Curaleaf Gets a Green Light for Acquisition Talk about maneuvering a minefield, eh? Curaleaf Holdings just stamped out the last of its paperwork in the cutthroat cannabis industry to acquire Aurora Cannabis. We're looking at the final sign-offs from not one, but two major players: Germany and Canada's competition authorities. That's no small feat when you're trying to...

Continue Reading
NHTSA, Ad Council Unveil New Anti-Buzzed Driving PSAs

Updated Category News Views 51

Taking Aim at a Deadly Habit Everyone's got that gut feeling when a day-long meeting runs over or you're stuck in traffic — impatience morphed with slow burn menace. Now picture a whole campaign gunning for that vibe but in the hands of the young folks, those from 21 to 34. That's what we're talking about here, with the Ad Council and NHTSA serving up some fresh public...

Continue Reading
CURE Intl and Thoughtworks Step Into Digital Era

Updated Category News Views 126

Pushing Paper Out, Digitizing In In a world where tech is king, why were hospitals—crucial, life-saving institutions—still bogged down by dusty folders and ink smudges? Well, not anymore for CURE International, not with Thoughtworks stepping up to the plate. This ain't just swapping paper for pixels; it's a lifeline for kids getting world-class surgical care without...

Continue Reading
Ampa One Partners with Wave Neuroscience for PTSD

Updated Category News Views 51

Ampa and Wave Neuroscience Join Forces In a fresh twist on the neurotechnology scene, Ampa's portable TMS system is teaming up with Wave Neuroscience's MeRT to target PTSD. Science and partnership—combined like a decent scotch and a well-done steak, if you ask me. They've got the FDA clearance on their side, and they're bringing it to the clinics without demanding those...

Continue Reading
High Stakes at Bragg Companies' Crane Auction

Updated Category News Views 74

Cranes, Cash, and Competition: Auction Insights Never thought a bunch of cranes and trucks could have me so interested, but here we are staring down one of the big ones this December. Bragg Companies plans to lift the lid on its fleet with an absolute auction conducted by none other than Jeff Martin Auctioneers. If you aren't in the loop, 'absolute' means no min bid,...

Continue Reading
Kavalan Whisky Expands into Ghana with Say Cheers

Updated Category News Views 122

A Taste of Taiwan in Ghana The whisky world just got a bit smaller with Kavalan’s latest move If you know whisky, you know Kavalan, the Taiwanese gem that's been steadily building its global footprint. And now, they've set their sights on Ghana. Yup, this one's not about rattling sabers but raising glasses! Partnering with Say Cheers Limited, Kavalan enters Ghana,...

Continue Reading
Cepheid Expands Diagnostic Potential with IVDR Approval

Updated Category News Views 106

A Key Milestone for Cepheid Breathing new life into Europe's diagnostic landscape, Cepheid's Xpert Respiratory Panel just snagged the CE marking under the IVDR. This ain't just some technical checkbox; this test's got the goods to spot 13 respiratory pathogens from one measly swab. It's a hefty lineup—think Adenovirus, different flavors of flu, and even the sneaky...

Continue Reading
The DOG CATCHER: A New Spin on Pet Waste Cleanup

Updated Category News Views 26

Revolutionizing the Dreaded Pet Waste Duty Folks, here's a little dose of innovation from the streets of Baltimore: a gadget called the DOG CATCHER. No, it’s not about catching stray dogs, but dealing with their unpleasant leavings. This invention's got a patent pending and all, promising to make the nasty business of dog waste collection a whole lot less disgusting. I...

Continue Reading
Autoliv Welcomes Rosenberg: Strategy Shift or Status Quo?

Updated Category News Views 183

Big Moves in the Boardroom Autoliv's latest announcement has stirred up the automotive safety world—a development that might feel like just another board shuffle, but there's more here than meets the eye. On November 10, 2026, Autoliv decided to toss Joachim Rosenberg into the mix as an independent director, bumping its board headcount from nine to ten. Who's This...

Continue Reading
McKinley Irvin Adds Veteran Willa Staats to Legal Team

Updated Category News Views 50

New Talent Joins a Leading Family Law Firm Some folks think of family law as just another branch of the legal world, but let's be real—it's where emotions run high and stakes can catch you off guard like a sudden market downturn. So, when McKinley Irvin, one of the Pacific Northwest’s top family law outfits, brings someone new aboard, that’s worth putting under the...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Trading: TruTrade's Approach to Capital Access

Updated Category News Views 135

Transforming Access to Capital in Trading In the competitive landscape of trading, both professional and independent traders are realizing that success is no longer just about having the best strategies. Instead, the focus is shifting towards scalable capital infrastructure, a crucial element that can enhance one’s trading performance. Introducing QuickFund AI—a...

Continue Reading
NeurAxis Secures Historic FDA Clearance for Pain Treatment

Updated Category News Views 157

NeurAxis Revolutionizes Treatment for Functional Dyspepsia NeurAxis, Inc. (NYSE American: NRXS), a pioneer in medical technology, has achieved a momentous milestone by securing FDA clearance for its innovative percutaneous electrical nerve field stimulation (PENFS) technology. This approval is specifically aimed at treating functional abdominal pain (FAP) associated with...

Continue Reading
Obic Co Ltd Maintains Price Target Amid Downgrade Insights

Updated Category News Views 91

Understanding the Recent Downgrade of Obic Co Ltd Recently, there has been some notable movement in the evaluation of Obic Co Ltd (4684:JP) (OTC: OBIIF) shares. Jefferies, a respected financial services company, has downgraded Obic's stock from a Buy rating to Hold. This revision comes amidst shifting market dynamics that have brought a renewed focus on domestic demand...

Continue Reading
Varonis to Report Third Quarter Results and Conference Call

Updated Category News Views 89

Varonis to Report Third Quarter Results Soon Varonis Systems, Inc. (Nasdaq: VRNS), renowned for its innovative data security solutions, is preparing to announce its financial performance for the third quarter of 2024. Stakeholders and analysts alike are keenly awaiting this report, which will be released after the U.S. markets close, specifically on a Tuesday at the end...

Continue Reading
Innovative AvePoint Elements Transform MSP Service Delivery

Updated Category News Views 125

Advancements in Managed Services with AvePoint Elements AvePoint (NASDAQ: AVPT) is steering a monumental shift in the managed services landscape with the launch of its next-generation AvePoint Elements. This innovative solution promises to revamp client, cloud, and tenant management for managed service providers (MSPs) by harnessing the power of artificial intelligence,...

Continue Reading